Aptamer Chimeras for Therapeutic Delivery: The Challenging Perspectives
Nucleic acid-based aptamers have emerged as efficient delivery carriers of therapeutics. Thanks to their unique features, they can be, to date, considered one of the best targeting moieties, allowing the specific recognition of diseased cells and avoiding unwanted off-target effects on healthy tissu...
Main Authors: | Carla Lucia Esposito, Silvia Catuogno, Gerolama Condorelli, Paola Ungaro, Vittorio de Franciscis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-10-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/9/11/529 |
Similar Items
-
Aptamer-Mediated Targeted Delivery of Therapeutics: An Update
by: Silvia Catuogno, et al.
Published: (2016-11-01) -
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
by: Carla Lucia Esposito, et al.
Published: (2018-03-01) -
Nucleic Acid Aptamers Targeting Epigenetic Regulators: An Innovative Therapeutic Option
by: Silvia Catuogno, et al.
Published: (2018-08-01) -
Coupling Aptamers to Short Interfering RNAs as Therapeutics
by: Vittorio de Franciscis, et al.
Published: (2011-10-01) -
Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells
by: David Porciani, et al.
Published: (2015-01-01)